StockData
Moderna, Inc. logo

Moderna, Inc. (MRNA) stock

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30537% above fair value
$196.79−10.01 (-4.84%)

Close on Nov 18, 2026Market cap $78.57BP/E –Yield –

Moderna market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Moderna's market cap was $99.23B on Nov 11, 2026, against $10.16B a year earlier. Over the last 5 years it ranged from $9.37B to $102.86B, with a median of $40.71B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$99.23B+760.6%
2025Dec 31, 2025$11.53B-28.0%
2024Dec 31, 2024$16.01B-57.8%
2023Dec 29, 2023$37.89B-45.5%
2022Dec 30, 2022$69.51B-32.4%
2021Dec 31, 2021$102.86B+149.0%
2020Dec 31, 2020$41.31B+535.1%
2019Dec 31, 2019$6.50B+553.2%
2018Dec 31, 2018$995.71M–

More Moderna figures

See a number that looks wrong?